Should the Patent System for New Medicines Be Abolished?

Clinical Pharmacology & Therapeutics (2007) 82, 488–490. doi:10.1038/sj.clpt.6100393

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2007-11, Vol.82 (5), p.488-490
Main Authors: DiMasi, J A, Grabowski, H G
Format: Article
Language:English
Subjects:
Biomedical Research - legislation & jurisprudence
Commerce - legislation & jurisprudence
Cost-Benefit Analysis
Drug Costs - legislation & jurisprudence
Drug Industry - legislation & jurisprudence
Financing, Government
Humans
Insurance Coverage
Legislation, Drug - standards
Legislation, Drug - trends
Orphan Drug Production - legislation & jurisprudence
Patents as Topic - legislation & jurisprudence
Pharmaceutical Preparations - economics
Public Policy
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinical Pharmacology & Therapeutics (2007) 82, 488–490. doi:10.1038/sj.clpt.6100393
ISSN:0009-9236
1532-6535
DOI:10.1038/sj.clpt.6100393